Continuous heart monitoring in patients with pulmonary hypertension smartwatches and direct transmission to their electronic health records: A trial design.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Continuous heart monitoring in patients with pulmonary hypertension smartwatches and direct transmission to their electronic health records : A trial design. / Ørbæk Andersen, Mads; Carlsen, Jørn.

I: Contemporary Clinical Trials, Bind 142, 107548, 2024.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Ørbæk Andersen, M & Carlsen, J 2024, 'Continuous heart monitoring in patients with pulmonary hypertension smartwatches and direct transmission to their electronic health records: A trial design.', Contemporary Clinical Trials, bind 142, 107548. https://doi.org/10.1016/j.cct.2024.107548

APA

Ørbæk Andersen, M., & Carlsen, J. (2024). Continuous heart monitoring in patients with pulmonary hypertension smartwatches and direct transmission to their electronic health records: A trial design. Contemporary Clinical Trials, 142, [107548]. https://doi.org/10.1016/j.cct.2024.107548

Vancouver

Ørbæk Andersen M, Carlsen J. Continuous heart monitoring in patients with pulmonary hypertension smartwatches and direct transmission to their electronic health records: A trial design. Contemporary Clinical Trials. 2024;142. 107548. https://doi.org/10.1016/j.cct.2024.107548

Author

Ørbæk Andersen, Mads ; Carlsen, Jørn. / Continuous heart monitoring in patients with pulmonary hypertension smartwatches and direct transmission to their electronic health records : A trial design. I: Contemporary Clinical Trials. 2024 ; Bind 142.

Bibtex

@article{baac8d5d7e144124b5618ac80392f295,
title = "Continuous heart monitoring in patients with pulmonary hypertension smartwatches and direct transmission to their electronic health records: A trial design.",
abstract = "Background: Pulmonary hypertension is a progressive disease for which early treatment interventions are essential. Traditionally, patients undergo periodic clinical assessments. However, recent advances in wearable technology could improve the quality and efficiency of follow-up monitoring in patients with pulmonary hypertension. Trial design: To our knowledge, this is the first study describing direct data transmission from a smartwatch to patients' electronic health records. It implements a novel update and customised program to continuously and automatically transmit data from a smartwatch to the patient's electronic healthcare records. It will evaluate continuous monitoring in patients with pulmonary hypertension and monitor their physical activity time, heart rate variability, and heart rate at rest and during physical activity via a smartwatch. It will also evaluate the data transmission method, and its data will be assessed by the treating physicians supplemental to clinical practice. Smartwatch integration promises numerous advantages: comprehensive cardiovascular monitoring and improved patient experience. Our continuous smartwatch monitoring approach offers a solution for earlier detection of clinical worsening and could be included as a combined endpoint in future clinical trials. It could improve patient empowerment, enhance precision medicine, and reduce hospitalisations. The user-friendly smartwatch is designed to minimise disruption in daily life. Conclusion: The ability to transfer real-time data from wearable devices to electronic health records could help to transform the treatment of patients with pulmonary hypertension and their follow-up monitoring outside a clinical setting, enhancing the efficiency of healthcare delivery.",
keywords = "Cardiovascular disease, Continuous heart monitoring, Electronic health records, Pulmonary hypertension, Remote patient monitoring, Risk assessment, Wearable devices",
author = "{{\O}rb{\ae}k Andersen}, Mads and J{\o}rn Carlsen",
note = "Publisher Copyright: {\textcopyright} 2023",
year = "2024",
doi = "10.1016/j.cct.2024.107548",
language = "English",
volume = "142",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Continuous heart monitoring in patients with pulmonary hypertension smartwatches and direct transmission to their electronic health records

T2 - A trial design.

AU - Ørbæk Andersen, Mads

AU - Carlsen, Jørn

N1 - Publisher Copyright: © 2023

PY - 2024

Y1 - 2024

N2 - Background: Pulmonary hypertension is a progressive disease for which early treatment interventions are essential. Traditionally, patients undergo periodic clinical assessments. However, recent advances in wearable technology could improve the quality and efficiency of follow-up monitoring in patients with pulmonary hypertension. Trial design: To our knowledge, this is the first study describing direct data transmission from a smartwatch to patients' electronic health records. It implements a novel update and customised program to continuously and automatically transmit data from a smartwatch to the patient's electronic healthcare records. It will evaluate continuous monitoring in patients with pulmonary hypertension and monitor their physical activity time, heart rate variability, and heart rate at rest and during physical activity via a smartwatch. It will also evaluate the data transmission method, and its data will be assessed by the treating physicians supplemental to clinical practice. Smartwatch integration promises numerous advantages: comprehensive cardiovascular monitoring and improved patient experience. Our continuous smartwatch monitoring approach offers a solution for earlier detection of clinical worsening and could be included as a combined endpoint in future clinical trials. It could improve patient empowerment, enhance precision medicine, and reduce hospitalisations. The user-friendly smartwatch is designed to minimise disruption in daily life. Conclusion: The ability to transfer real-time data from wearable devices to electronic health records could help to transform the treatment of patients with pulmonary hypertension and their follow-up monitoring outside a clinical setting, enhancing the efficiency of healthcare delivery.

AB - Background: Pulmonary hypertension is a progressive disease for which early treatment interventions are essential. Traditionally, patients undergo periodic clinical assessments. However, recent advances in wearable technology could improve the quality and efficiency of follow-up monitoring in patients with pulmonary hypertension. Trial design: To our knowledge, this is the first study describing direct data transmission from a smartwatch to patients' electronic health records. It implements a novel update and customised program to continuously and automatically transmit data from a smartwatch to the patient's electronic healthcare records. It will evaluate continuous monitoring in patients with pulmonary hypertension and monitor their physical activity time, heart rate variability, and heart rate at rest and during physical activity via a smartwatch. It will also evaluate the data transmission method, and its data will be assessed by the treating physicians supplemental to clinical practice. Smartwatch integration promises numerous advantages: comprehensive cardiovascular monitoring and improved patient experience. Our continuous smartwatch monitoring approach offers a solution for earlier detection of clinical worsening and could be included as a combined endpoint in future clinical trials. It could improve patient empowerment, enhance precision medicine, and reduce hospitalisations. The user-friendly smartwatch is designed to minimise disruption in daily life. Conclusion: The ability to transfer real-time data from wearable devices to electronic health records could help to transform the treatment of patients with pulmonary hypertension and their follow-up monitoring outside a clinical setting, enhancing the efficiency of healthcare delivery.

KW - Cardiovascular disease

KW - Continuous heart monitoring

KW - Electronic health records

KW - Pulmonary hypertension

KW - Remote patient monitoring

KW - Risk assessment

KW - Wearable devices

U2 - 10.1016/j.cct.2024.107548

DO - 10.1016/j.cct.2024.107548

M3 - Journal article

C2 - 38679139

AN - SCOPUS:85191511006

VL - 142

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

M1 - 107548

ER -

ID: 391116581